[Reduction of aconitine and adrenaline tachycardia by the antifibrillating substance trimepranol in the rat heart in situ and in the isolated frog heart (comparative study) (author's transl)].
D000157:Aconitine; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001001:Anura; D004195:Disease Models, Animal; D004837:Epinephrine; D010647:Phenyl Ethers / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013610:Tachycardia / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D010647:Phenyl Ethers; D011412:Propanolamines; D000157:Aconitine; D004837:Epinephrine
Snízení akonitinové a adrenalinové tachykardie antifibrilaćní latkou trimepranol u krysího srdce in situ a u izolovaného zabího srdce